Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia

Stock Information for Acasti Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.